Immunic, Inc. (IMUX)
0.94
-0.03
(-3.56%)
USD |
NASDAQ |
Feb 20, 16:00
0.925
-0.02
(-1.60%)
Pre-Market: 20:00
Immunic EPS Diluted (Quarterly) : -0.1319 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| BioRestorative Therapies, Inc. | -0.3333 |
| Quince Therapeutics, Inc. | -0.2492 |
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Agenus, Inc. | 1.944 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -25.58M |
| Total Expenses (Quarterly) | 25.58M |
| Enterprise Value | 78.73M |
| Earnings Yield | -92.06% |
| Normalized Earnings Yield | -92.06 |